ICL reports 2Q26 results

Consolidated sales of US$2.1 billion were up 17% vs US$1.8 billion in 2025. Operating income was uS$266 million vs US$181 million in 2Q25, while adjusted operating income of US$281 million was up US$80 million vs US$201 million. For 2Q26, net income attributable to shareholders was US$137 million vs US$93 million in 2025, with adjusted net income of US$149 million up 35% compared to US$110 million.

Adjusted EBITDA of US$448 million was up nearly US$100 million vs US$351 million. Diluted earnings per share were US$0.11 vs US$0.07 in 2Q25, with adjusted diluted EPS of US$0.12 up 33% vs US$0.09. Operating cash flow of US$290 million was up vs US$269 million in 2025, while free cash flow of US$94 million was up 34%.

“ICL exceeded expectations in 2Q26 and reported solid growth across all key financial metrics, both on an annual and sequential basis, and each of our four businesses contributed to the strong sales performance. Once again, we benefited from our distinctive global presence, as our regionally diversified sales and operations teams remained close to our customers and end markets. We successfully leveraged market dynamics where opportunities emerged, while continuing to diligently manage forces outside of our control and to swiftly respond to changes in market conditions,” said Elad Aharonson, president and CEO of ICL.

"As part of the execution of our strategy, we intend to realign our organisational structure at the beginning of 2027. This new structure is expected to strengthen management focus on our key growth engines and align the business with our strategic priorities. We expect this update to our structure will provide investors with enhanced visibility into the performance, growth drivers and value creation potential of our businesses.

“The new structure will be comprised of three end market-focused business divisions: the newly established Nutrition Solutions division will bring together all of our food and beverage, health, nutrition and wellness offerings in one place to address multiple end markets; Industrial Products will be focused on performance and safety solutions for all of our industrial end markets; and Growing Solutions will remain focused on specialty plant nutrition for agriculture, turf and ornamental end markets. Our fourth segment, Essential Minerals, will include potash and phosphate fertilizers from our upstream mineral production sites – including our potash resources in the Dead Sea and Spain and our phosphate resources in the Negev and China – and will continue to serve global agriculture end markets. Additional details are available in our financial schedules, and we will discuss further on our earnings call later today.

“During 2Q26, we also formalised our enterprise-wide cost savings initiative, known as Elevate. This programme is designed to reduce our cost base, support margin expansion, improve cash generation and strengthen earnings power. Implementation began in 3Q26, and we expect to deliver more than US$350 million of annualised savings by the end of 2028 and to begin realising significant savings in early 2027,” concluded Aharonson.

Read the full report here.

Read the article online at: https://www.worldfertilizer.com/nitrogen/07082026/icl-reports-second-quarter-2026-results/